当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 现金流量表

康美药业

(600518)

  

流通市值:178.31亿  总市值:178.39亿
流通股本:138.22亿   总股本:138.29亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,929,463,774.262,543,779,811.431,100,733,187.995,487,861,781.14
  收到其他与经营活动有关的现金59,514,945.0740,541,169.716,643,475.2495,413,442.67
  经营活动现金流入小计3,988,978,719.332,584,320,981.131,117,376,663.235,583,275,223.81
  购买商品、接受劳务支付的现金2,967,203,467.551,920,556,938.52868,846,629.964,211,733,743.29
  支付给职工以及为职工支付的现金551,056,974.43367,303,581.68195,260,163.38752,389,109.84
  支付的各项税费107,111,775.9268,886,503.8925,998,607.56155,538,840.35
  支付其他与经营活动有关的现金265,759,220.1191,521,113.5382,026,611.59352,266,902.46
  经营活动现金流出小计3,891,131,4382,548,268,137.621,172,132,012.495,471,928,595.94
  经营活动产生的现金流量净额97,847,281.3336,052,843.51-54,755,349.26111,346,627.87
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额2,842,571.492,632,998.792,149,941.539,788,889.32
  收到的其他与投资活动有关的现金--1-
  投资活动现金流入小计2,842,571.492,632,998.792,149,942.539,788,889.32
  购建固定资产、无形资产和其他长期资产支付的现金43,572,038.7326,197,047.8915,701,885.89217,059,298.38
  支付其他与投资活动有关的现金3,573,576.433,573,576.43--
  投资活动现金流出小计47,145,615.1629,770,624.3215,701,885.89217,059,298.38
  投资活动产生的现金流量净额-44,303,043.67-27,137,625.53-13,551,943.39-177,270,409.06
三、筹资活动产生的现金流量:
  吸收投资收到的现金400,000--1,800,000
  其中:子公司吸收少数股东投资收到的现金400,000--1,800,000
  取得借款收到的现金1,000,0001,000,0001,000,000-
  收到其他与筹资活动有关的现金99,080,722.4591,461,627.5841,312,265.95375,520,528.09
  筹资活动现金流入小计100,480,722.4592,461,627.5842,312,265.95377,320,528.09
  偿还债务支付的现金---43,500,000
  分配股利、利润或偿付利息支付的现金1,174,337.58506,686.11250,000295,878.4
  其中:子公司支付给少数股东的股利、利润1,160,240.36500,000250,000295,878.4
  支付其他与筹资活动有关的现金24,884,769.1816,609,527.768,337,100.344,274,406.54
  筹资活动现金流出小计26,059,106.7617,116,213.878,587,100.388,070,284.94
  筹资活动产生的现金流量净额74,421,615.6975,345,413.7133,725,165.65289,250,243.15
四、汇率变动对现金及现金等价物的影响-35,951.69-28,399.8-16,599.73-13,988.28
五、现金及现金等价物净增加额127,929,901.6684,232,231.89-34,598,726.73223,312,473.68
  加:期初现金及现金等价物余额1,066,292,345.451,066,292,345.451,066,292,345.45842,979,871.77
  期末现金及现金等价物余额1,194,222,247.111,150,524,577.341,031,693,618.721,066,292,345.45
补充资料:
  净利润-37,367,319.7-12,429,169.97
  资产减值准备-7,977,435.04-184,382,843.48
  固定资产和投资性房地产折旧-128,142,732.59-255,874,663.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-128,142,732.59-255,874,663.21
  无形资产摊销-8,635,944.01-21,880,963.63
  长期待摊费用摊销-11,277,884.57-21,053,236.84
  处置固定资产、无形资产和其他长期资产的损失--3,735,062.72--846,811.6
  固定资产报废损失-302,021.81-1,464,525.08
  公允价值变动损失--24,790.51--6,681.98
  财务费用-2,487,700.45-18,388,961.03
  投资损失--81,612,440.05--90,603,779.48
  递延所得税-423,078.85-2,637,517.69
  其中:递延所得税资产减少-973,862.54-10,189,631.01
    递延所得税负债增加--550,783.69--7,552,113.32
  存货的减少--100,395,613.15-96,050,179.07
  经营性应收项目的减少-148,116,118.1--128,258,484.48
  经营性应付项目的增加--146,109,083.86--290,337,008.43
  现金的期末余额-1,150,524,577.34-1,066,292,345.45
  减:现金的期初余额-1,066,292,345.45-842,979,871.77
  现金及现金等价物的净增加额-84,232,231.89-223,312,473.68
公告日期2026-10-312026-08-262026-04-302026-04-18
审计意见(境内)标准无保留意见
TOP↑